Patent · US Active

Method of purifying therapeutic proteins

US9598461B2 · kind B2 · utility

0Cited by

13References

28Claims

0Family size

Assignee

CSL Behring AG · DE

Inventors

Hung Pham · San Jose, US
Jeffrey Michael Hey · Cottles Bridge, AU
Darren Nguy · Melbourne, AU

Key dates

Filing date	Nov 6, 2014
Grant date	Mar 21, 2017
Priority date	—
Expiry date	Nov 6, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates generally to a method of reducing the level of at least one protein selected from the group consisting of plasminogen, tissue plasminogen activator and other protease(s) in a solution comprising at least one protein selected from the group consisting of fibrinogen, Factor VIII and von Willebrand factor (VWF), the method comprising: Also provided are solutions and pharmaceutical formulations comprising the fibrinogen and/or Factor VIII and/or VWF recovered by such methods, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.